Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Stilgenbauer

Showing results (331-340 of 466) with videos related to

Pageof 47
Sort By:
Blood|May 7, 2014
Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemiaNatali Pflug, Jasmin Bahlo, Tait D Shanafelt, et al.
Leukemia Research|March 26, 2015
Final results of EFC6663: a multicenter, international, phase 2 study of alvocidib for patients with fludarabine-refractory chronic lymphocytic leukemiaMark C Lanasa, Leslie Andritsos, Jennifer R Brown, et al.
Genes, Chromosomes & Cancer|February 26, 2022
T-cell prolymphocytic leukemia is associated with deregulation of oncogenic microRNAs on transcriptional and epigenetic levelPaurnima Patil, Sina Hillebrecht, Emil Chteinberg, et al.
European Journal of Haematology|December 9, 2015
Bendamustine and rituximab in combination with lenalidomide in patients with chronic lymphocytic leukemiaChristian Maurer, Natali Pflug, Jasmin Bahlo, et al.
Leukemia|June 2, 2025
NOTCH1 signaling is dysregulated by loss of the deubiquitinase USP28 with del(11q), uncovering USP28 inhibition as novel therapeutic target in CLLAlena Sophie Ehrmann, Miguel Quijada-Álamo, Viola Close, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 9, 2012
Quantitative DNA methylation analysis identifies a single CpG dinucleotide important for ZAP-70 expression and predictive of prognosis in chronic lymphocytic leukemiaRainer Claus, David M Lucas, Stephan Stilgenbauer, et al.
Blood Advances|January 30, 2024
Six-year follow-up and subgroup analyses of a phase 2 trial of venetoclax for del(17p) chronic lymphocytic leukemiaStephan Stilgenbauer, Eugen Tausch, Andrew W Roberts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2019
Treatment of Older Patients With Mantle Cell Lymphoma (MCL): Long-Term Follow-Up of the Randomized European MCL Elderly TrialHanneke C Kluin-Nelemans, Eva Hoster, Olivier Hermine, et al.
Molecular Systems Biology|May 24, 2019
Linking aberrant chromatin features in chronic lymphocytic leukemia to transcription factor networksJan-Philipp Mallm, Murat Iskar, Naveed Ishaque, et al.
Cell Death & Disease|July 31, 2019
Prediction of venetoclax activity in precursor B-ALL by functional assessment of apoptosis signalingFelix Seyfried, Salih Demir, Rebecca Louise Hörl, et al.
Pageof 47

Showing results (331-340 of 466) with videos related to

Sort By:
Pageof 47
Blood|May 7, 2014
Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemiaNatali Pflug, Jasmin Bahlo, Tait D Shanafelt, et al.
Leukemia Research|March 26, 2015
Final results of EFC6663: a multicenter, international, phase 2 study of alvocidib for patients with fludarabine-refractory chronic lymphocytic leukemiaMark C Lanasa, Leslie Andritsos, Jennifer R Brown, et al.
Genes, Chromosomes & Cancer|February 26, 2022
T-cell prolymphocytic leukemia is associated with deregulation of oncogenic microRNAs on transcriptional and epigenetic levelPaurnima Patil, Sina Hillebrecht, Emil Chteinberg, et al.
European Journal of Haematology|December 9, 2015
Bendamustine and rituximab in combination with lenalidomide in patients with chronic lymphocytic leukemiaChristian Maurer, Natali Pflug, Jasmin Bahlo, et al.
Leukemia|June 2, 2025
NOTCH1 signaling is dysregulated by loss of the deubiquitinase USP28 with del(11q), uncovering USP28 inhibition as novel therapeutic target in CLLAlena Sophie Ehrmann, Miguel Quijada-Álamo, Viola Close, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 9, 2012
Quantitative DNA methylation analysis identifies a single CpG dinucleotide important for ZAP-70 expression and predictive of prognosis in chronic lymphocytic leukemiaRainer Claus, David M Lucas, Stephan Stilgenbauer, et al.
Blood Advances|January 30, 2024
Six-year follow-up and subgroup analyses of a phase 2 trial of venetoclax for del(17p) chronic lymphocytic leukemiaStephan Stilgenbauer, Eugen Tausch, Andrew W Roberts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2019
Treatment of Older Patients With Mantle Cell Lymphoma (MCL): Long-Term Follow-Up of the Randomized European MCL Elderly TrialHanneke C Kluin-Nelemans, Eva Hoster, Olivier Hermine, et al.
Molecular Systems Biology|May 24, 2019
Linking aberrant chromatin features in chronic lymphocytic leukemia to transcription factor networksJan-Philipp Mallm, Murat Iskar, Naveed Ishaque, et al.
Cell Death & Disease|July 31, 2019
Prediction of venetoclax activity in precursor B-ALL by functional assessment of apoptosis signalingFelix Seyfried, Salih Demir, Rebecca Louise Hörl, et al.
Pageof 47